|
WO2020041871A1
|
|
Method for treating lysosomal storage disease
|
|
AU2019239797A1
|
|
Weight management composition
|
|
WO2019071353A1
|
|
Use of system xc- inhibitor for treating statin-induced myalgia
|
|
US2020230197A1
|
|
Multi-nutrient composition
|
|
WO2017147719A1
|
|
Method for treating neuropathy
|
|
WO2017147720A1
|
|
Method for treating a central nervous system disorder
|
|
WO2017075708A1
|
|
Exosomes useful to treat cystic fibrosis
|
|
WO2017054086A1
|
|
Treatment of genetic myopathies using bioengineered exosomes
|
|
WO2016187717A1
|
|
Exosomes useful for genome editing
|
|
WO2016115632A1
|
|
Method for treating mitochondrial disease
|
|
CA2962081A1
|
|
Exosomes useful to treat lysosomal storage disease
|
|
WO2016033695A1
|
|
Exosome isolation
|
|
CA2917944A1
|
|
Therapeutic method of inducing mitochondrial biogenesis
|
|
WO2014183207A1
|
|
Therapeutic method of treating metabolic syndrome
|
